209 related articles for article (PubMed ID: 24733895)
21. Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.
Noren NK; Lu M; Freeman AL; Koolpe M; Pasquale EB
Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5583-8. PubMed ID: 15067119
[TBL] [Abstract][Full Text] [Related]
22. Serotonin transporter interacts with the PDGFβ receptor in PDGF-BB-induced signaling and mitogenesis in pulmonary artery smooth muscle cells.
Ren W; Watts SW; Fanburg BL
Am J Physiol Lung Cell Mol Physiol; 2011 Mar; 300(3):L486-97. PubMed ID: 21186266
[TBL] [Abstract][Full Text] [Related]
23. Regulation of signaling interactions and receptor endocytosis in growing blood vessels.
Pitulescu ME; Adams RH
Cell Adh Migr; 2014; 8(4):366-77. PubMed ID: 25482636
[TBL] [Abstract][Full Text] [Related]
24. Ligand-dependent EphB4 activation serves as an anchoring signal in glioma cells.
Kawahara Y; Furuta T; Sabit H; Tamai S; Dong Y; Jiapaer S; Zhang J; Zhang G; Oishi M; Miyashita K; Hayashi Y; Nakada M
Cancer Lett; 2019 May; 449():56-65. PubMed ID: 30776480
[TBL] [Abstract][Full Text] [Related]
25. Transactivation of PDGFRbeta by dopamine D4 receptor does not require PDGFRbeta dimerization.
Chi SS; Vetiska SM; Gill RS; Hsiung MS; Liu F; Van Tol HH
Mol Brain; 2010 Jul; 3():22. PubMed ID: 20659339
[TBL] [Abstract][Full Text] [Related]
26. Platelet-derived growth factor signaling through ephrin-b2 regulates hepatic vascular structure and function.
Semela D; Das A; Langer D; Kang N; Leof E; Shah V
Gastroenterology; 2008 Aug; 135(2):671-9. PubMed ID: 18570897
[TBL] [Abstract][Full Text] [Related]
27. The Ubiquitin Ligases c-Cbl and Cbl-b Negatively Regulate Platelet-derived Growth Factor (PDGF) BB-induced Chemotaxis by Affecting PDGF Receptor β (PDGFRβ) Internalization and Signaling.
Rorsman C; Tsioumpekou M; Heldin CH; Lennartsson J
J Biol Chem; 2016 May; 291(22):11608-18. PubMed ID: 27048651
[TBL] [Abstract][Full Text] [Related]
28. The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway.
Noren NK; Foos G; Hauser CA; Pasquale EB
Nat Cell Biol; 2006 Aug; 8(8):815-25. PubMed ID: 16862147
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effects of resveratrol on PDGF-BB-induced retinal pigment epithelial cell migration via PDGFRβ, PI3K/Akt and MAPK pathways.
Chan CM; Chang HH; Wang VC; Huang CL; Hung CF
PLoS One; 2013; 8(2):e56819. PubMed ID: 23457620
[TBL] [Abstract][Full Text] [Related]
30. Ephrin-independent regulation of cell substrate adhesion by the EphB4 receptor.
Noren NK; Yang NY; Silldorff M; Mutyala R; Pasquale EB
Biochem J; 2009 Aug; 422(3):433-42. PubMed ID: 19552627
[TBL] [Abstract][Full Text] [Related]
31. EphB4 signaling is capable of mediating ephrinB2-induced inhibition of cell migration.
Sturz A; Bader B; Thierauch KH; Glienke J
Biochem Biophys Res Commun; 2004 Jan; 313(1):80-8. PubMed ID: 14672701
[TBL] [Abstract][Full Text] [Related]
32. Histidine-domain-containing protein tyrosine phosphatase regulates platelet-derived growth factor receptor intracellular sorting and degradation.
Ma H; Wardega P; Mazaud D; Klosowska-Wardega A; Jurek A; Engström U; Lennartsson J; Heldin CH
Cell Signal; 2015 Nov; 27(11):2209-19. PubMed ID: 26232618
[TBL] [Abstract][Full Text] [Related]
33. Glycogen synthase kinase 3 regulates PAX3-FKHR-mediated cell proliferation in human alveolar rhabdomyosarcoma cells.
Zeng FY; Dong H; Cui J; Liu L; Chen T
Biochem Biophys Res Commun; 2010 Jan; 391(1):1049-55. PubMed ID: 19995556
[TBL] [Abstract][Full Text] [Related]
34. Tyrosine Kinase Inhibitors Regulate OPG through Inhibition of PDGFRβ.
O'Sullivan S; Tay ML; Lin JM; Bava U; Callon K; Cornish J; Naot D; Grey A
PLoS One; 2016; 11(10):e0164727. PubMed ID: 27737004
[TBL] [Abstract][Full Text] [Related]
35. Imatinib attenuates end-organ damage in hypertensive homozygous TGR(mRen2)27 rats.
Schellings MW; Baumann M; van Leeuwen RE; Duisters RF; Janssen SH; Schroen B; Peutz-Kootstra CJ; Heymans S; Pinto YM
Hypertension; 2006 Mar; 47(3):467-74. PubMed ID: 16432052
[TBL] [Abstract][Full Text] [Related]
36. The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth.
Kertesz N; Krasnoperov V; Reddy R; Leshanski L; Kumar SR; Zozulya S; Gill PS
Blood; 2006 Mar; 107(6):2330-8. PubMed ID: 16322467
[TBL] [Abstract][Full Text] [Related]
37. P-cadherin is a direct PAX3-FOXO1A target involved in alveolar rhabdomyosarcoma aggressiveness.
Thuault S; Hayashi S; Lagirand-Cantaloube J; Plutoni C; Comunale F; Delattre O; Relaix F; Gauthier-Rouvière C
Oncogene; 2013 Apr; 32(15):1876-87. PubMed ID: 22710718
[TBL] [Abstract][Full Text] [Related]
38. EphB4 provides survival advantage to squamous cell carcinoma of the head and neck.
Masood R; Kumar SR; Sinha UK; Crowe DL; Krasnoperov V; Reddy RK; Zozulya S; Singh J; Xia G; Broek D; Schönthal AH; Gill PS
Int J Cancer; 2006 Sep; 119(6):1236-48. PubMed ID: 16615113
[TBL] [Abstract][Full Text] [Related]
39. The Fer tyrosine kinase is important for platelet-derived growth factor-BB-induced signal transducer and activator of transcription 3 (STAT3) protein phosphorylation, colony formation in soft agar, and tumor growth in vivo.
Lennartsson J; Ma H; Wardega P; Pelka K; Engström U; Hellberg C; Heldin CH
J Biol Chem; 2013 May; 288(22):15736-44. PubMed ID: 23589302
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of platelet-derived growth factor receptorbeta by imatinib mesylate suppresses proliferation and alters differentiation of human mesenchymal stem cells in vitro.
Fierro F; Illmer T; Jing D; Schleyer E; Ehninger G; Boxberger S; Bornhäuser M
Cell Prolif; 2007 Jun; 40(3):355-66. PubMed ID: 17531080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
